Smith & Nephew PLC (SNN)
23.88
-0.69
(-2.81%)
USD |
NYSE |
Apr 25, 16:00
24.51
+0.63
(+2.64%)
Pre-Market: 09:20
Smith & Nephew Total Liabilities (Quarterly): 4.77B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.77B |
June 30, 2023 | 4.611B |
June 30, 2023 | 4.611B |
December 31, 2022 | 4.707B |
June 30, 2022 | 4.71B |
June 30, 2022 | 4.71B |
December 31, 2021 | 5.352B |
June 30, 2021 | 5.602B |
June 30, 2021 | 5.602B |
December 31, 2020 | 5.733B |
June 30, 2020 | 4.579B |
June 30, 2020 | 4.579B |
December 31, 2019 | 4.158B |
June 30, 2019 | 3.994B |
June 30, 2019 | 3.994B |
December 31, 2018 | 3.185B |
June 30, 2018 | 3.07B |
June 30, 2018 | 3.07B |
December 31, 2017 | 3.222B |
June 30, 2017 | 3.238B |
June 30, 2017 | 3.238B |
December 31, 2016 | 3.386B |
June 30, 2016 | 3.558B |
June 30, 2016 | 3.558B |
December 31, 2015 | 3.201B |
Date | Value |
---|---|
June 30, 2015 | 3.166B |
June 30, 2015 | 3.166B |
December 31, 2014 | 3.266B |
September 30, 2014 | 3.633B |
June 30, 2014 | 3.587B |
June 30, 2014 | 3.587B |
March 31, 2014 | 1.724B |
December 31, 2013 | 1.772B |
September 30, 2013 | 1.656B |
June 30, 2013 | 1.557B |
March 31, 2013 | 1.512B |
December 31, 2012 | 1.758B |
September 30, 2012 | 1.355B |
June 30, 2012 | 1.255B |
March 31, 2012 | 1.431B |
December 31, 2011 | 1.56B |
September 30, 2011 | 1.764B |
June 30, 2011 | 1.776B |
March 31, 2011 | 1.787B |
December 31, 2010 | 1.96B |
September 30, 2010 | 2.40B |
June 30, 2010 | 2.273B |
March 31, 2010 | 2.309B |
December 31, 2009 | 2.386B |
September 30, 2009 | 2.618B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.994B
Minimum
Jun 2019
5.733B
Maximum
Dec 2020
4.781B
Average
4.707B
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
AstraZeneca PLC | 61.95B |
Adaptimmune Therapeutics PLC | 243.10M |
Biodexa Pharmaceuticals Plc | 7.470M |
Verona Pharma PLC | 58.84M |
NuCana PLC | 16.46M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 9.987B |
Shareholders Equity (Quarterly) | 5.217B |
Debt to Equity Ratio | 0.553 |
Current Ratio | 1.774 |
Net Debt Paydown Yield | -0.47% |